Comparative immune response to PE and PE_PGRS antigens of Mycobacterium tuberculosis

被引:160
作者
Delogu, G [1 ]
Brennan, MJ [1 ]
机构
[1] US FDA, Lab Mycobacterial Dis & Cell Immunol, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA
关键词
D O I
10.1128/IAI.69.9.5606-5611.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sequencing of the entire genome of Mycobacterium tuberculosis identified a novel multigene family composed of two closely related subfamilies designated PE and PE PGRS. The major difference between these two families is the presence of a domain containing numerous Gly-Ala repeats extending to the C terminus of the PE PGRS genes. We have used a representative PE PGRS gene from M. tuberculosis, Rv1818c (1818(PE_PGRS)), and its amino-terminal PE region (1818(PE)), to investigate the immunological response to these proteins during experimental tuberculosis and following immunization with DNA constructs. During infection of mice with M. tuberculosis, a significant humoral immune response was observed against recombinant 1818(PE_PGRS) but not toward the 1818PE protein. Similarly, immunization with a 1818(PE_PGRS) DNA construct induced antibodies directed against 1818(PE_PGRS) but not against 1818PE proteins, and no humoral response was induced by 1818(PE) DNA. These results suggest that certain PE_PGRS genes are expressed during infection of the host with M. tuberculosis and that an antibody response is directed solely against the Gly-Ala-rich PGRS domain. Conversely, splenocytes from 1818(PE)-vaccinated mice but not mice immunized with 1818(PE_PGRS) secreted gamma interferon following in vitro restimulation and demonstrated protection in the mouse tuberculosis challenge model. These results suggest that the PE vaccine can elicit an effective cellular immune response and that immune recognition of the PE antigen is influenced by the Gly-Ala-rich PGRS domain.
引用
收藏
页码:5606 / 5611
页数:6
相关论文
共 29 条
  • [1] GENETIC AND IMMUNOLOGICAL ANALYSIS OF MYCOBACTERIUM-TUBERCULOSIS FIBRONECTIN-BINDING PROTEINS
    ABOUZEID, C
    GARBE, T
    LATHIGRA, R
    WIKER, HG
    HARBOE, M
    ROOK, GAW
    YOUNG, DB
    [J]. INFECTION AND IMMUNITY, 1991, 59 (08) : 2712 - 2718
  • [2] [Anonymous], 1988, Antibodies: A Laboratory Manual
  • [3] Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs
    Barry, CE
    Slayden, RA
    Sampson, AE
    Lee, RE
    [J]. BIOCHEMICAL PHARMACOLOGY, 2000, 59 (03) : 221 - 231
  • [4] Comparative genomics of BCG vaccines by whole-genome DNA microarray
    Behr, MA
    Wilson, MA
    Gill, WP
    Salamon, H
    Schoolnik, GK
    Rane, S
    Small, PM
    [J]. SCIENCE, 1999, 284 (5419) : 1520 - 1523
  • [5] Learning from the genome sequence of Mycobacterium tuberculosis H37Rv
    Cole, ST
    [J]. FEBS LETTERS, 1999, 452 (1-2) : 7 - 10
  • [6] Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
    Cole, ST
    Brosch, R
    Parkhill, J
    Garnier, T
    Churcher, C
    Harris, D
    Gordon, SV
    Eiglmeier, K
    Gas, S
    Barry, CE
    Tekaia, F
    Badcock, K
    Basham, D
    Brown, D
    Chillingworth, T
    Connor, R
    Davies, R
    Devlin, K
    Feltwell, T
    Gentles, S
    Hamlin, N
    Holroyd, S
    Hornby, T
    Jagels, K
    Krogh, A
    McLean, J
    Moule, S
    Murphy, L
    Oliver, K
    Osborne, J
    Quail, MA
    Rajandream, MA
    Rogers, J
    Rutter, S
    Seeger, K
    Skelton, J
    Squares, R
    Squares, S
    Sulston, JE
    Taylor, K
    Whitehead, S
    Barrell, BG
    [J]. NATURE, 1998, 393 (6685) : 537 - +
  • [7] PROTECTION TO MICE AFFORDED BY BCG VACCINES AGAINST AN AEROGENIC CHALLENGE BY 3 MYCOBACTERIA OF DECREASING VIRULENCE
    COLLINS, FM
    [J]. TUBERCLE, 1985, 66 (04): : 267 - 276
  • [8] DNA vaccination against tuberculosis: Expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity
    Delogu, G
    Howard, A
    Collins, FM
    Morris, SL
    [J]. INFECTION AND IMMUNITY, 2000, 68 (06) : 3097 - 3102
  • [9] Functional domains present in the mycobacterial hemagglutinin, HBHA
    Delogu, G
    Brennan, MJ
    [J]. JOURNAL OF BACTERIOLOGY, 1999, 181 (24) : 7464 - 7469
  • [10] ANTIBODIES AGAINST A SYNTHETIC PEPTIDE IDENTIFY THE EPSTEIN-BARR VIRUS-DETERMINED NUCLEAR ANTIGEN
    DILLNER, J
    STERNAS, L
    KALLIN, B
    ALEXANDER, H
    EHLINHENRIKSSON, B
    JORNVALL, H
    KLEIN, G
    LERNER, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (15): : 4652 - 4656